These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 36594088)
21. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer. Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936 [TBL] [Abstract][Full Text] [Related]
22. ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis. Yang J; Shu G; Chen T; Dong A; Dong C; Li W; Sun X; Zhou Y; Li D; Zhou J Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201620 [TBL] [Abstract][Full Text] [Related]
23. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
24. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian Cancer Patients: Evidence from Bioinformatics and In Vitro Level. Song Y; Zhang J; Zhang L; Zhang S; Shen C Comput Math Methods Med; 2022; 2022():7397250. PubMed ID: 36276992 [TBL] [Abstract][Full Text] [Related]
25. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Cai L; Leng ZG; Guo YH; Lin SJ; Wu ZR; Su ZP; Lu JL; Wei LF; Zhuge QC; Jin K; Wu ZB Endocrine; 2016 Jun; 52(3):641-51. PubMed ID: 26662185 [TBL] [Abstract][Full Text] [Related]
26. Identification and Validation of MYADM as a Novel Prognostic Marker Related to EMT in ESCC. Yang Q; Cai B; Zhu S; Tai G; Shen A J Cancer; 2024; 15(16):5351-5366. PubMed ID: 39247591 [No Abstract] [Full Text] [Related]
27. Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells. Bender O; Gunduz M; Cigdem S; Hatipoglu OF; Acar M; Kaya M; Grenman R; Gunduz E; Ugur KS J Oral Pathol Med; 2018 Jan; 47(1):40-47. PubMed ID: 29024069 [TBL] [Abstract][Full Text] [Related]
28. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells. Yang X; Zhou S; Yang C; Cao C; He M; Zi S Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876 [TBL] [Abstract][Full Text] [Related]
29. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer. Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492 [TBL] [Abstract][Full Text] [Related]
30. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification. Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715 [TBL] [Abstract][Full Text] [Related]
31. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells. Feng W; Ting Y; Tang X; Liu D; Zhou WC; Li Y; Shen Z Heliyon; 2024 Sep; 10(17):e36897. PubMed ID: 39281564 [TBL] [Abstract][Full Text] [Related]
32. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
33. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer. Wang Y; Li BX; Li X Front Oncol; 2021; 11():783666. PubMed ID: 35047401 [TBL] [Abstract][Full Text] [Related]
35. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978 [TBL] [Abstract][Full Text] [Related]
36. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway. Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567 [TBL] [Abstract][Full Text] [Related]
37. EMS1/DLL4-Notch Signaling Axis Augments Cell Cycle-Mediated Tumorigenesis and Progress in Human Adrenocortical Carcinoma. Huang YG; Wang Y; Zhu RJ; Tang K; Tang XB; Su XM Front Oncol; 2021; 11():771579. PubMed ID: 34858850 [TBL] [Abstract][Full Text] [Related]
38. Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression. Chen CM; Lin CL; Chiou HL; Hsieh SC; Lin CL; Cheng CW; Hung CH; Tsai JP; Hsieh YH Oncotarget; 2017 Feb; 8(8):13886-13897. PubMed ID: 28108731 [TBL] [Abstract][Full Text] [Related]
39. Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysis. Chen W; Liu D; Wang G; Pan Y; Wang S; Tang R Transl Cancer Res; 2022 Jun; 11(6):1722-1729. PubMed ID: 35836534 [TBL] [Abstract][Full Text] [Related]
40. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer. He Y; Lin L; Ou Y; Hu X; Xu C; Wang C Open Med (Wars); 2022; 17(1):1376-1389. PubMed ID: 36117773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]